Clinical Trials Directory

Trials / Terminated

TerminatedNCT01528072

Dynesys Spinal System Post Market 522 Study

Post Market Surveillance for the Dynesys Spinal System, Assessing Safety and Fusion.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
153 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System used as an adjunct to fusion and compare to literature control.

Detailed description

Study is meant to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System.

Conditions

Interventions

TypeNameDescription
DEVICEDynesys Spinal SystemDynesys Spinal System will be used for all subjects

Timeline

Start date
2012-03-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2012-02-07
Last updated
2020-01-29
Results posted
2020-01-29

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01528072. Inclusion in this directory is not an endorsement.

Dynesys Spinal System Post Market 522 Study (NCT01528072) · Clinical Trials Directory